Total Payments
$5,153
2024 Payments
$2,019
Companies
15
Transactions
263
Medicare Patients
493
Medicare Billing
$75,127
Payment Breakdown by Category
Food & Beverage$5,041 (97.8%)
Education$112.14 (2.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,041 | 261 | 97.8% |
| Education | $112.14 | 2 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $982.59 | 50 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $946.98 | 49 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $667.19 | 25 | $0 (2024) |
| Lundbeck LLC | $603.67 | 36 | $0 (2024) |
| Alkermes, Inc. | $446.80 | 19 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $255.29 | 14 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $240.45 | 17 | $0 (2024) |
| Indivior Inc. | $230.07 | 13 | $0 (2024) |
| ITI, Inc. | $209.18 | 11 | $0 (2023) |
| Axsome Therapeutics, Inc. | $200.87 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,019 | 113 | Janssen Pharmaceuticals, Inc ($308.38) |
| 2023 | $2,465 | 113 | ABBVIE INC. ($660.63) |
| 2022 | $669.25 | 37 | Otsuka America Pharmaceutical, Inc. ($177.86) |
All Payment Transactions
263 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Neuropsychiatry | ||||||
| 12/12/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $7.28 | General |
| Category: Neuroscience | ||||||
| 12/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $2.59 | General |
| Category: Neuropsychiatry | ||||||
| 12/12/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $1.33 | General |
| Category: Neuroscience | ||||||
| 12/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $5.78 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $9.16 | General |
| Category: Neuroscience | ||||||
| 11/15/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: CNS | ||||||
| 11/12/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: OUD | ||||||
| 10/31/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $21.48 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/11/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: OUD | ||||||
| 10/09/2024 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $6.88 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $0.99 | General |
| Category: PSYCHIATRY | ||||||
| 09/27/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: CNS | ||||||
| 09/26/2024 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $20.41 | General |
| Category: PSYCHIATRY | ||||||
| 09/25/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $5.71 | General |
| Category: Neuropsychiatry | ||||||
| 09/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| Category: PSYCHIATRY | ||||||
| 09/17/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: OUD | ||||||
| 09/12/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: OUD | ||||||
| 09/12/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $6.23 | General |
| Category: Neuroscience | ||||||
| 09/05/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: PSYCHIATRY | ||||||
| 08/27/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: PSYCHIATRY | ||||||
| 08/27/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $7.30 | General |
| Category: Neurology | ||||||
| 08/27/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $5.61 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 12 | 21 | $2,625 | $1,013 |
| 2022 | 1 | 17 | 198 | $34,650 | $9,392 |
| 2021 | 3 | 49 | 151 | $23,744 | $7,535 |
| 2020 | 8 | 415 | 925 | $183,505 | $57,186 |
Total Patients
493
Total Services
1,295
Medicare Billing
$75,127
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 12 | 21 | $2,625 | $1,013 | 38.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 17 | 198 | $34,650 | $9,392 | 27.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 24 | 97 | $16,490 | $4,600 | 27.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 13 | 14 | $3,934 | $1,896 | 48.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 12 | 40 | $3,320 | $1,040 | 31.3% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2020 | 155 | 484 | $87,120 | $26,439 | 30.3% |
| 99336 | Established patient assisted living visit, typically 40 minutes | Office | 2020 | 58 | 181 | $47,965 | $15,140 | 31.6% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2020 | 66 | 112 | $15,120 | $4,904 | 32.4% |
| 99304 | Initial nursing facility visit, typically 25 minutes per day | Office | 2020 | 55 | 56 | $10,080 | $3,474 | 34.5% |
| 99335 | Established patient assisted living visit, typically 25 minutes | Office | 2020 | 27 | 36 | $6,840 | $2,212 | 32.3% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Office | 2020 | 27 | 28 | $7,420 | $1,993 | 26.9% |
| 99326 | New patient assisted living visit, typically 45 minutes | Office | 2020 | 16 | 16 | $4,400 | $1,520 | 34.5% |
| 99337 | Established patient assisted living visit, typically 60 minutes | Office | 2020 | 11 | 12 | $4,560 | $1,504 | 33.0% |
About Kristen Karohl
Kristen Karohl is a Medical healthcare provider based in Seven Hills, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/09/2017. The National Provider Identifier (NPI) number assigned to this provider is 1942748926.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kristen Karohl has received a total of $5,153 in payments from pharmaceutical and medical device companies, with $2,019 received in 2024. These payments were reported across 263 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($5,041).
As a Medicare-enrolled provider, Karohl has provided services to 493 Medicare beneficiaries, totaling 1,295 services with total Medicare billing of $75,127. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Location Seven Hills, OH
- Active Since 02/09/2017
- Last Updated 12/09/2020
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1942748926
Products in Payments
- VRAYLAR (Drug) $982.59
- REXULTI (Drug) $765.24
- INVEGA SUSTENNA (Drug) $537.00
- ABILIFY MAINTENA (Drug) $452.78
- CAPLYTA (Drug) $449.63
- ARISTADA (Drug) $357.53
- ABILIFY ASIMTUFII (Drug) $332.63
- INGREZZA (Drug) $255.29
- Auvelity (Drug) $200.87
- UZEDY (Drug) $133.63
- SPRAVATO (Drug) $123.64
- SUBLOCADE (Drug) $121.79
- JORNAY PM (Drug) $113.48
- PERSERIS (Drug) $108.28
- VIVITROL (Drug) $74.42
- Austedo XR (Drug) $64.77
- HETLIOZ (Drug) $23.34
- AZSTARYS (Drug) $19.35
- QELBREE (Drug) $14.99
- LYBALVI (Drug) $14.85
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.